sellWeak
Stacy J. Kanter sold $4,816 of APLT
director at Applied Therapeutics, Inc.. 43,000 shares at an average of $0.11, traded Dec 16, 2025, filed Dec 18, 2025.
Warning score
25Value
$4,816
43,000 shares
Holdings after
65,000
-40% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- 0Trade size$5k at market
- +10Share of holdings soldSold 40% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001193125-25-324476, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 16, 2025 | SOpen-market sale Common Stock | -43,000 | $0.11 | $4,816 | 65,000 | Dec 18, 2025 |
Related signals
Other insiders at Applied Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | Applied Therapeutics, Inc. | Constantine Chinoporos See Remarks | $197 447 shares | -0% | |
| 30Weak | Applied Therapeutics, Inc. | Leslie D. Funtleyder See Remarks | $6,381 14,502 shares | -4% | |
| 30Weak | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $4,561 10,366 shares | -1% | |
| 30Weak | Applied Therapeutics, Inc. | Constantine Chinoporos See Remarks | $17k 28,117 shares | -9% | |
| 37Weak | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $53k 86,078 shares | -9% | |
| 30Weak | Applied Therapeutics, Inc. | Leslie D. Funtleyder See Remarks | $14k 22,950 shares | -5% | |
| 45Moderate | Applied Therapeutics, Inc. | Leslie D. Funtleyder Chief Financial Officer | $73k 16,980 shares | -6% | |
| 40Moderate | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $95k 22,003 shares | -2% | |
| 53Moderate | Applied Therapeutics, Inc. | Shoshana Shendelman President and CEO | $267k 61,795 shares | -2% | |
| 52Moderate | Applied Therapeutics, Inc. | Alexandria Real Estate Equities, Inc. owner | $1.3M 300,000 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.